Don't worry, be happy: positive affect and reduced 10-year incident coronary heart disease: The Canadian Nova Scotia Health Survey by Davidson, Karina W. et al.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
CLINICAL RESEARCH
Coronary heart disease
Don’t worry, be happy: positive affect and
reduced 10-year incident coronary heart disease:
The Canadian Nova Scotia Health Survey
Karina W. Davidson*, Elizabeth Mostofsky, and William Whang
Department of Medicine, Center for Behavioral Cardiovascular Health, Columbia University Medical Center, 622 West 168th Street, PH9 Room 948, New York, NY 10032, USA
Received 19 August 2009; revised 7 December 2009; accepted 17 December 2009; online publish-ahead-of-print 17 February 2010
See page 1036 for the editorial comment on this article (doi:10.1093/eurheartj/ehq031)
Aims Positive affect is believed to predict cardiovascular health independent of negative affect. We examined whether
higher levels of positive affect are associated with a lower risk of coronary heart disease (CHD) in a large prospective
study with 10 years of follow-up.
Methods
and results
We examined the association between positive affect and cardiovascular events in 1739 adults (862 men and 877
women) in the 1995 Nova Scotia Health Survey. Trained nurses conducted Type A Structured Interviews, and
coders rated the degree of outwardly displayed positive affect on a five-point scale. To test that positive affect pre-
dicts incident CHD when controlling for depressive symptoms and other negative affects, we used as covariates:
Center for Epidemiological Studies Depressive symptoms Scale, the Cook Medley Hostility scale, and the Spielberger
Trait Anxiety Inventory. There were 145 (8.3%) acute non-fatal or fatal ischaemic heart disease events during the
14 916 person-years of observation. In a proportional hazards model controlling for age, sex, and cardiovascular
risk factors, positive affect predicted CHD (adjusted HR, 0.78; 95% CI 0.63–0.96 per point; P ¼ 0.02), the covariate
depressive symptoms continued to predict CHD as had been published previously in the same patients (HR, 1.04;
95% CI 1.01–1.07 per point; P ¼ 0.004) and hostility and anxiety did not (both P . 0.05).
Conclusion In this large, population-based study, increased positive affectwas protective against 10-year incidentCHD, suggesting that
preventive strategies may be enhanced not only by reducing depressive symptoms but also by increasing positive affect.
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Introduction
Previous studies have found that positive affect is associated with
increased survival, improved immune function, and lower risk of
diabetes and hypertension,1–4 whereas negative emotions such
as anger/hostility5 and depression6,7 are associated with a higher
risk of incident coronary heart disease (CHD). Positive affect is
defined as the experience of pleasurable emotions such as joy, hap-
piness, excitement, enthusiasm, and contentment.8 These feelings
can be transient, but they are usually stable and trait-like, particu-
larly in adulthood.3 Interestingly, positive affect is largely indepen-
dent of negative affect, as someone who is generally a happy,
contented person can also occasionally be anxious, angry, or
depressed.9 Positive affect has been proposed as a protective
factor for ill-health for many years.1–3 However, there has been
little research to address the question of whether positive affect
protects against CHD.2,4,10 We therefore examined whether clini-
cally assessed positive affect is associated with a reduced risk of




The Canadian Nova Scotia Health study11 is a population-based survey
implemented by Heart Health Nova Scotia in partnership with the Nova
Scotia Department of Health to estimate the distributions of selected
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health indicators and preventive practices of Nova Scotians. The sample
was constructed based on a probability sample designed by Statistics
Canada, the national statistical agency and census bureau, to be repre-
sentative of the Nova Scotian population by age, gender, and geographic
location. The targeted population consisted of all non-institutionalized
Nova Scotians aged 18 and above whose names were listed in the
Medical Service Insurance register, the government-sponsored, univer-
sal health insurance plan. The overall recruitment percentage (72%) is
comparable to other large health surveys, and weights applied from pro-
pensity analyses to test for response bias revealed no meaningful
biases.12 Pregnant women were excluded from the survey, as their
CHD risk factors (e.g. weight, blood pressure, diabetes, etc.) were not
considered stable at entry.
A group of 29 public health nurses took part in a 5-day training session
on how to properly contact the identified participants and how to accu-
rately collect data using the standardizedmeasures. FromMarch through
November 1995, the nurses collected data by contacting survey partici-
pants, immediately interviewing thosewho agreed to participate. Partici-
pants were asked to attend health-care clinic 7 days after the interview
for assessment of height and weight and to provide a fasting blood
sample for lipid determination and sample banking. During the clinic
visit, participants were asked to complete a structured interview that
was videotaped for subsequent scoring. Further details of the study pro-
cedures have been previously published.11,13
Participants provided written consent, allowing linkage to their future
and past health-care utilization data and for the storage and future use of
videotapes. We restricted our sample to those who had attended the
clinic session and completed the structured interview with no hospital
discharge diagnoses of CHD in the 5 years prior to the baseline
survey, determined by their single-payer electronic medical records
(see below). IRB approval was originally obtained for the baseline proto-
col and was subsequently obtained for these analyses at both Dalhousie
University in Canada and Columbia University in New York.
Assessment of coronary heart disease risk
factors
At the baseline visit, we measured the levels of each component of the
Framingham risk score, including sex, age, total cholesterol, HDL choles-
terol, blood pressure, history of diabetes, and cigarette smoking.14
Nurses measured weight and height twice and reported the average of
the two measurements for each. The averaged values were used to cal-
culate body mass index (calculated as weight in kilograms divided by
height in metres squared). Participants also reported if a physician had
ever diagnosed them as having diabetes mellitus. Registered nurses
measured resting systolic (SBP) and diastolic (DBP) blood pressures
using a manual random zero sphygmomanometer. Two readings from
home and two readings from the clinic session (usually 1 week later)
were averaged to create the resting SBP and DBP measurements.
Total cholesterol and high-density cholesterol were assayed from
plasma samples by the Lipid Research Laboratory, University of
Toronto.15 Low-density lipoprotein cholesterol was calculated using
the Friedewald formula.16 Those who reported smoking in the last
year or who reported smoking currently were categorized as
smokers, and the remainder were coded as non-smokers.
Assessment of self-reported psychosocial risk
factors
Three negative affect measures were included as covariates to test if
positive affect was independently predictive of incident CHD.
Depressive symptoms
Depressive symptoms were measured using the Centers for Epidemio-
logical Studies-Depressive symptoms (CES-D) scale,17 a 20-item self-
report instrument that was designed for use in epidemiological
studies as a measure of current level of depressive symptoms.
Higher scores reflect increased depressive symptoms.
Hostility
Hostility was assessed with the Cook-Medley Hostility scale;18 50
true–false items commonly used to assess self-reported hostility.19,20
Anxious symptoms
Anxious symptoms were assessed with the Trait-subscale of the State-
Trait Anxiety scale,21 a 20-item test that describes symptoms of
anxiety (e.g. I worry too much over something that really doesn’t
matter). The scale requires respondents to indicate how frequently
they experience a variety of anxiety symptoms using a four-point
Likert scale.
Clinically assessed positive affect
The Expanded Structured Interview is a 12 min, interpersonally stress-
ful interview designed to assess anger expression and stress reactions
by asking participants about their characteristic responses to a variety
of different situations.22 The interview is based on the original Type A
Structured Interview,23 with additional questions on anger expression
and interpersonal stress at work. Positive affect is a rating of the degree
to which the participant expresses positive emotions, whether verbally
or in behaviour (e.g. smiling) or tone of responses (e.g. cheerful). Posi-
tive affect may be demonstrated during the interview or can be based
on the participant’s level of positive affect reported to occur during
day-to-day situations.
There are four steps to the creation of observer-based positive
affect scores.24 First, nurse interviewers were trained and certified
to conduct the structured interview and ensure that it was properly
recorded on videotape. Second, the recorded interview was viewed
to ensure the interviewer followed the script, and only those that
passed interview quality filters were included. Third, staff were
trained on how to properly code the interviews. Fourth, coding was
randomly audited and only those staff passing preset reliability require-
ments were retained.
All interviews were scored for positive affect, rated from 1 (no posi-
tive affect expressed) to 5 (extreme positive affect) by the 23 certified
coders. All coders additionally rated a common 30 tapes (unbe-
knownst to them). Three coders were found to be unreliable, and
their tapes were then reassessed by another, reliable coder from the
original bank of coders, whose data were then checked again at the
end of the coding phase.
Surveillance of incident coronary heart
disease
The main outcome variable was discharge documentation of incident
fatal or nonfatal ischaemic heart disease determined by hospital dis-
charge codes or death certificates [International Classification of Dis-
eases (ICD)-9 codes25 (410–414) and ICD-10 codes26 (I21–I25). This
included acute myocardial infarction (MI) and other forms of acute
ischaemic heart disease, but excluded old or previous MIs (codes
412 and I22/I25.2). Because of the universal health care insurance
system in Nova Scotia, data from the provincial health-care database
provide accurate documentation for hospitalizations and outpatient
visits of all residents, regardless of event or treatment location.27
Immediately upon discharge, physicians submit ICD codes to
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Department of Health. A data quality committee from the Department
of Health of Nova Scotia meets regularly with health records person-
nel to ensure accuracy, conduct random chart reviews, and to adjudi-
cate discrepancies in data entry. In order to limit the analyses to
incident events, we excluded anyone with a CHD diagnosis prior to
their baseline survey by searching for documentation of a CHD
event in the 5 years prior to their survey date using the data
sources described above.
All deaths are reported to provincial offices, which in turn notify the
national census bureau, Statistics Canada, which applies a nationally
consistent process of determining the underlying cause of death.
Specifically, these data were converted to the ICD codes by staff at
Statistics Canada, and only those codes listed above qualified as fatal
CHD. Data were extracted by Population Health Unit of Dalhousie
University. Participants were observed for up to 10 years, from the
date of their initial visit in 1995 until the earliest of the following:
10-year anniversary of their initial visit date or March 2005 or the
date of emigration, death from causes other than CHD, or documen-
ted incident CHD.
Data analysis
We conducted t-tests and x2 tests on levels of cardiovascular risk
factors to compare those with vs. those without an available positive
affect score. The Cochran–Armitage test for trend was used to test
for a linear trend in binomial proportions across levels of positive
affect, and analysis of variance contrast analysis was used to test for
linear trends in mean levels of continuous measures. Coder reliability
was assessed by calculating the correlation between each coders’
ratings and the average of the other coders’ ratings (corrected
item–total correlation) on the common 30 tapes.28 We constructed
Cox proportional hazards models to estimate the adjusted hazard
ratios of incident CHD by level of positive affect. Models were adjusted
for age at baseline, sex, cardiovascular risk factors, and three negative
affect scales of depression, hostility, and anxiety. All models were stra-
tified by geographic region of the sampling frame. Because some of the
participants were missing data on baseline characteristics, we calcu-
lated the average of the hazard ratio estimates based on five Markov
chain Monte Carlo multiple imputations of the data set.29 We tested
the proportional hazards assumption using the Kolmogorov-type
supremum test30 based on 1000 simulated replications, and there
was no evidence of violation of this assumption (P ¼ 0.64). We exam-
ined the association between positive affect and CHD incidence non-
parametrically with restricted cubic splines to provide a more accurate
representation of the dose–response curve. Tests for non-linearity
used the likelihood ratio test, comparing the model with only the
linear term to the model with the linear and the cubic spline
terms.31 All analyses were performed using SAS statistical software
(version 9.1), and statistical significance was defined by a two-sided
P  0.05.
Results
This prospective study included 1739 participants (862 men, 877
women) from the Nova Scotia Health Survey who were greater
than 18 years old with no known CHD at baseline and who com-
pleted the survey, clinic exam, and structured interview. Compared
with the 481 NSHS95 participants with no positive affect score,
the 1739 included participants were younger (average age ¼ 46.2
vs. 49; t ¼ 22.87, P ¼ 0.004), less hostile (19.0 vs. 20.7; t ¼2
3.32, P ¼ 0.001), they were less likely to be male (44.0% vs.
49.5%; x ¼ 4.47; P ¼ 0.035), and they had higher levels of diastolic
pressures (average ¼ 77.0 vs. 75.8; t ¼ 2.14, P ¼ 0.033). Table 1
shows the baseline characteristics of the 1739 participants included
in the analysis. Those with higher levels of positive affect were
more likely to be female (P, 0.001), less likely to be current
smokers (P, 0.001), and they had lower levels of total cholesterol
(P ¼ 0.03), SBP (P ¼ 0.008), and DBP (P ¼ 0.006), levels of hosti-
lity (P, 0.001) and anxious symptoms (P ¼ 0.03), suggesting that
higher levels of positive affect are related to better overall health.
Coder reliability among pairs of coders was 0.90. No single coder
appeared to be an outlier when examining the corrected item–total
correlations. Positive affect was only minimally correlated with the
negative affect measures of depressive symptoms (r ¼ 20.04),
hostility (r ¼ 20.12), and anxious symptoms (r ¼ 20.05),
suggesting these measures had little common variance.
There were 145 (8.3%) incident CHD events (136 non-fatal, 9
fatal) during the 14 916 person-years of observation (incidence
rate, 9.72 events/1000 person-years). Table 2 presents the Cox
proportional hazards regression analyses. Even after adjusting for
age, sex, cardiovascular risk factors, and negative affect, the rate
of incident CHD was 22% lower for one point increase in positive
affect score (95% CI 0.63–0.96; P ¼ 0.02). The test for linear
relation indicated that the association is indeed linear (P ¼ 0.04).
Figure 1 presents multivariate adjusted dose–response curve
using a cubic spline in the fully adjusted model.
Discussion
In this large, randomly selected population-based study, increased
positive affect was associated with a reduced risk of 10-year inci-
dent CHD, even after adjustment for depressive symptoms, hosti-
lity, and anxiety. To our knowledge, this is the first prospective
study to examine this relationship.
Recent studies have begun to explore the protective effects of
positive affect on physical health, including cardiovascular risk
factors such as hypertension and diabetes.1–3 Prospective observa-
tional studies have reported an inverse association between posi-
tive affect and incident stroke32 and mortality in medical
in-patients33 as well as diabetic patients,34 and others have
shown that positive affect is protective against recurrent major
clinical events in patients with cardiac stents.35 In the largest
study to date, the Whitehall II cohort study did not find evidence
of positive affect protecting against incident CHD, independent of
negative affect.36 However, these studies utilized measurements of
positive affect that were not ideal.37 In fact, some of these studies
measured positive affect using instruments that were designed to
assess depressive symptoms. In this analysis, trained observers esti-
mated levels of positive affect rather than relying on self-reported
levels or items originally designed to assess negative affect.
Positive affect, joy, happiness, and excitement, have previously
been shown to be largely independent of negative affect.9 In our
data, there was also a negligible correlation between positive
affect and depressive symptoms. We had previously found that
depressive symptoms were a significant predictor of CHD inci-
dence in this sample, and so thought it was important to control
for this important psychosocial risk factor.38 Our findings are con-
sistent with an independent and clinically relevant relationship
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between CHD and positive affect (22% relative risk reduction for
each one-point increment in positive affect on a five-point scale), a
relationship that was not attenuated by adjustment for depressive
symptoms.
Possible pathophysiological mechanisms
Various mechanisms may explain the potential cardiovascular
benefits of higher levels of positive affect. For example, positive
affect, but not negative affect, has been shown to predict enhanced
parasympathetic modulation of heart rate.39 Positive affect is
associated with blunted SBP, DBP, and norepinephrine reactivity
during a standardized, stressful laboratory task and with lowered
30 min post-awakening cortisol levels in these same subjects.40
Increased positive affect may protect against CHD via improve-
ments in sleep habits and smoking cessation. Steptoe et al.41
have found that higher positive affect is predictive of better sleep
quality, independent of negative affect and other predictors of
poor sleep, and Strong et al.42 found that higher levels of positive
affect are associated with fewer urges to smoke during smoking
cessation treatment, independent of levels of negative affect.
However, further research is needed to explain the mechanisms
by which positive affect might confer long-term CHD
protection.3,43
Study limitations
Among the limitations of our analysis is the fact that information on
cardiovascular risk factors were only measured at baseline and
therefore, some misclassification is likely. Over the duration of
follow-up, it is likely that patients experienced changes in their car-
diovascular risk factors (e.g. development of diabetes), health
behaviors (e.g. changes in physical activity or smoking status) and
medications (e.g. starting or stopping cardio-protective drugs).
However, this misclassification would likely have been non-
differential and would lead to an underestimation of results. Simi-
larly, levels of positive affect were also only measured at baseline
and changes may have occurred over the 10 years of follow-up.
First impressions of positive affect, even by strangers, are remark-
ably reliable and are in high agreement with ratings done by trained
coders, life partners, clinicians, the person, and close friends.44
These ratings are also remarkably stable across decades of adult-
hood.45 It nevertheless remains possible that misclassification
occurred, which again would have led to underestimation of the
protection conferred by positive affect.
We aimed to exclude survey participants with pre-existing
CHD. Therefore, we excluded participants with any self-reported
CHD or CHD events documented in the patient charts for the 5
years prior to the survey date. However, since electronic records
did not exist prior to 1990, it is not possible to obtain information
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
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Table 1 Baseline characteristics by level of positive affect expression
Variable Levels of positive affect P-value
trenda
Total None Little Moderate Quite a bit Extreme
(N5 1739) (n5 168) (n 5 755) n5 592) (n5 193) (n5 31)
Age 46.2+18.0 45.6+18.1 47.1+17.8 45.7+18.4 44.7+17.5 45.6+19.3 0.24
Male 862 (49.6%) 112 (66.7%) 411 (54.4%) 264 (44.6%) 68 (35.2%) 7 (22.6%) ,0.001
Active smoking 451 (25.9%) 58 (34.5%) 206 (27.3%) 142 (24.0%) 38 (19.7%) 7 (22.6%) ,0.001
Body mass index (kg/m2) 27.1+5.6 27.5+5.5 27.1+5.4 27.1+5.8 26.4+4.9 27.7+7.4 0.23
Diabetes mellitus 65 (3.7%) 7 (4.2%) 32 (4.2%) 18 (3.0%) 7 (3.4%) 1 (3.2%) 0.41
Total cholesterol (mmol/L) 5.3+1.1 5.4+1.2 5.3+1.1 5.3+1.1 5.2+0.9 4.9+1.2 0.03
Low density lipids (mmol/L) 3.2+0.9 3.2+0.9 3.3+0.9 3.2+0.9 3.2+0.9 2.9+1.0 0.24
Systolic blood pressure (mmHg) 124.7+17.0 126.5+16.2 125.6+17.4 123.4+16.6 123.6+16.7 121.7+18.9 0.008
Diastolic blood pressure (mmHg) 77.0+9.7 78.7+10.0 77.3+10.0 76.4+9.4 76.1+9.4 76.6+10.7 0.006
Depressive symptoms 7.4+8.1 8.9+9.4 7.3+8.2 7.1+7.8 6.9+7.6 7.8+6.6 0.06
Hostility 19.0+8.1 21.1+8.3 19.4+8.4 18.4+7.9 17.4+7.1 17.3+6.5 ,0.001
Anxiety 36.6+8.4 37.6+9.8 36.9+8.2 36.3+8.3 36.0+7.9 35.5+8.6 0.03
ax2 Cochran–Armitage trend test or analysis of variance linear trends.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 2 Hazard ratios (and 95% confidence intervals)
for one unit increase in each psychosocial measure
Predictor Hazard rate (95% confidence interval)
Model 1a Model 2b Model 3c
Positive affect 0.73 (0.59–0.90) 0.77 (0.63–0.95) 0.78 (0.63–0.96)
Depressive
symptoms
1.04 (1.02–1.06) 1.03 (1.01–1.05) 1.04 (1.01–1.07)
Hostility 1.02 (1.00–1.04) 1.02 (1.00–1.04) 1.01 (0.99–1.03)
Anxious
symptoms
1.01 (0.99–1.03) 1.01 (0.99–1.03) 0.97 (0.95–1.00)
Baseline rates were allowed to vary by region.
aAdjusted for age at baseline (continuous) and sex.
bAdjusted for variables in Model 1 and smoking (smoking actively or within the
past year vs. all others), history of diabetes mellitus (yes/no), body mass index
(kg/m2), total cholesterol (mmol/L), low-density lipoprotein (mmol/L), systolic
blood pressure (mmHg), and diastolic blood pressure (mmHg), measured as
continuous terms.
cAdjusted for variables in Model 2 and symptoms of negative affect (continuous
variables).
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farther back. Therefore, some participants who may have experi-
enced prior CHD events more than 5 years before the baseline
survey and denied a history of CHD may have been included in
the current analysis. If those who experienced CHD events
more than 5 years prior to the baseline visit were also more
likely to demonstrate lower levels of positive affect, the results
may be an overestimate of the true association.
Since this is an observational study, we cannot rule out the
possibility of unmeasured or residual confounding. Participants
with data available on positive affect were younger, less likely to
be male, less likely to be hostile, and had higher blood pressures
than the participants without positive affect scores who were
excluded from this analysis. If those who were excluded differed
greatly in their risk of CHD and also in their (unknown) levels of
positive affect, it is possible that our results may be at least partially
accounted for by a selection bias. Therefore, confirmatory studies
are needed. Strengths of our analysis include the relatively large
sample size, use of a structured interview with standardized assess-
ment of positive affect, inclusion of standard negative affect scales
as covariates, and long-term follow-up.
Conclusions and clinical implications
In summary, in this prospective population-based study, we found
that positive affect was independently associated with risk of CHD.
The positive affect we assessed is relatively easy to judge in a clini-
cal situation. Does the patient smile and appear able to enjoy some
aspects of life during the clinical interview or medical history
taking? Do they report that they experience pleasure or excite-
ment with some parts of their daily life? Assessment of positive
affect may complement evaluations for CHD risk that only
assess negative emotions such as depression.
Potential interventions to augment positive affect are usually
labelled behavioral activation interventions,46 in which a patient
notes which hobbies, daily activities, or other habits are enjoyable,
with instructions to pursue those activities with increased and
documented daily frequency. Conducting such a simple interven-
tion results in patient-reported increases in quality of life. In fact,
most successful depression interventions include increasing posi-
tive affect, as well as decreasing negative affect, as key components
to psychotherapy.47 Furthermore, a recent study reports that the
use of antidepressants without psychotherapy can result in lower
levels of positive affect.48 Randomized controlled trials directly
increasing positive affect in cardiopulmonary patients are now
underway.49 However, as we report findings from an observational
study, we do not yet have evidence to suggest that regular assess-
ment of positive and negative affect should be recommended.
Whether increasing positive affect would decrease the risk for
CHD is an exciting, but as of yet untested hypothesis, remaining
to be addressed.
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